Hi, what are you looking for?
Jewish Business News
Search results for "nyse"
Business
Comcast executive David L. Cohen received some support from his boss Monday after a media report suggested the company needed a new lobbying voice...
Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Court
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Business
The company stated that the contracts reinforce ICL's standing as one of the world's main suppliers of potash to China, a rapidly growing potash...
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
Business
Despite the ongoing two-month strike, Israel Chemicals has agreed to supply Chinese customers with the potash in 2015.
World News
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Business
Comverse, formerly one of Israel’s flagship high-tech companies in the process of divesting its assets, is asking $400 million.